Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis. - Wikidata - wikimedia - TriplyDB

Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.

Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.

http://www.wikidata.org/entity/Q52908090

about

Neurodegeneration in multiple sclerosis: novel treatment strategies The unfolded protein response in multiple sclerosis Current automated 3D cell detection methods are not a suitable replacement for manual stereologic cell counting Amelioration of experimental autoimmune encephalomyelitis by plumbagin through down-regulation of JAK-STAT and NF-κB signaling pathways The expression of VEGF-A is down regulated in peripheral blood mononuclear cells of patients with secondary progressive multiple sclerosis Metabolic changes in the visual cortex are linked to retinal nerve fiber layer thinning in multiple sclerosis What went wrong? The flawed concept of cerebrospinal venous insufficiency.Effects of Bu Shen Yi sui capsule on NogoA/NgR and its signaling pathways RhoA/ROCK in mice with experimental autoimmune encephalomyelitis X-Ray Phase Contrast Tomography Reveals Early Vascular Alterations and Neuronal Loss in a Multiple Sclerosis Model.Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation.Bushen Yisui Capsule ameliorates axonal injury in experimental autoimmune encephalomyelitis.Is metabolic flexibility altered in multiple sclerosis patients?Glucose uptake heterogeneity of the leg muscles is similar between patients with multiple sclerosis and healthy controls during walking.The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis.Axonal damage in multiple sclerosis.Loss of CNS IL-2 gene expression modifies brain T lymphocyte trafficking: response of normal versus autoreactive Treg-deficient T cells.The role of environmental exposures in neurodegeneration and neurodegenerative diseases.Central nervous system rather than immune cell-derived BDNF mediates axonal protective effects early in autoimmune demyelination.Neurodegeneration in Autoimmune Optic Neuritis Is Associated with Altered APP Cleavage in Neurons and Up-Regulation of p53 K+ channel alterations in the progression of experimental autoimmune encephalomyelitis Inhibition of Vascular Endothelial Growth Factor Receptor 2 Exacerbates Loss of Lower Motor Neurons and Axons during Experimental Autoimmune Encephalomyelitis.Role of glial 14-3-3 gamma protein in autoimmune demyelination.Age-Related Uptake of Heavy Metals in Human Spinal Interneurons.Can we prevent or treat multiple sclerosis by individualised vitamin D supply?Lymphocytes with cytotoxic activity induce rapid microtubule axonal destabilization independently and before signs of neuronal death Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?Increased carbonylation, protein aggregation and apoptosis in the spinal cord of mice with experimental autoimmune encephalomyelitis.Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis.Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis Quantitative 3D investigation of Neuronal network in mouse spinal cord model.Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.Inflammation in neurodegenerative diseases.Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.Brain-derived neurotrophic factor in neuroimmunology: lessons learned from multiple sclerosis patients and experimental autoimmune encephalomyelitis models.Multiple sclerosis: basic knowledge and new insights in perioperative management.Immune responses to non-tumor antigens in the central nervous system.Chronic exercise confers neuroprotection in experimental autoimmune encephalomyelitis.Type 1 narcolepsy: a CD8(+) T cell-mediated disease?Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.Synaptic Phospholipid Signaling Modulates Axon Outgrowth via Glutamate-dependent Ca2+-mediated Molecular Pathways.

P2860

Q22241472-4864DCC4-3293-4E3E-BCDE-22FE9FF98AEB Q26797409-683853C7-79D0-4BBC-B221-23D5B631BA87 Q28364911-8C98AB91-8ECC-4800-ACCE-AACB6EF33F0D Q28477723-655E7955-FB8E-41D0-A180-8C1C5D25653E Q28740407-E42A513E-3F28-4F89-B571-D6411D51F775 Q28741362-0B15F7D6-E60A-4765-B530-303A54940C42 Q30454634-468B7A56-379B-4A3B-9C4F-FD117D38F0F8 Q33862545-CA755178-8C1B-4772-956D-6CAB52B5B97C Q33919133-52FA8FF2-1040-4082-8D7E-BA8ED68D3BF1 Q34055604-641C9096-C1EE-4350-AE2B-D7193ED1EA51 Q34094705-15ADC293-52E6-4006-A152-AD65C666AC81 Q34405459-AB34F40E-01F8-42EE-BEB2-E928349A7D17 Q35070023-C4530F6C-E8C8-4C25-ACAC-330B44086A2F Q35082344-2D849E48-5616-4D68-A944-B55E53B9988C Q35126104-4F20CED3-FB77-4F99-A18D-0B4DCDABD2F4 Q35147178-2B916D1E-3302-4CFE-8B33-A5823676F8BD Q35551001-E7BD5013-69FB-449C-B558-B957DDAA4E76 Q35675723-541036AD-41BE-41A5-B7FE-0DA4E26A973D Q35794898-0EA743DF-B067-4450-A3E3-80CC6C123262 Q36007543-2F96E1A7-3FFD-430B-821A-E63EE543B4C7 Q36088247-B6222D40-0F27-4718-9D39-74583AA0013E Q36127346-BAF93F7D-C8B7-431F-BF2B-A4CD52002513 Q36128036-DD8AD29D-C36C-4D2C-AC14-72D59ADF8B99 Q36588696-FDF975CF-8CB4-4B95-A2F9-C344D674DDC9 Q36590210-AAD82AB4-9689-487E-A91C-AD2BA70B172C Q36648907-A8411B42-C55F-4683-BB64-3F58C02028F7 Q36750834-6A047620-0DC0-49B9-A143-4414A806EB48 Q37403700-4D5F1DDF-93E2-49F6-AC70-BE3866A49A60 Q37493548-82232C7E-8C58-403F-A16B-A2C1D331F5B7 Q37598458-4B8B088A-D62A-4374-878E-F728C1C99D35 Q37708381-FDD7286B-5B62-4D74-BF1B-E7F3190FF626 Q37766302-CE9AD2C0-A818-4D08-B44D-BA5DE8F60FEB Q37800214-86DB8159-7B61-4620-B479-7B6880FCF7FF Q38071242-1DFD9558-A027-4E4F-8A66-4275DF385A27 Q38130445-E8B0D998-B099-4AE3-A5F0-30C21ABFE385 Q38272285-ED6F2B83-842C-4ECE-982C-6E989657BDB4 Q38446276-38C20E71-6838-4C95-BFE4-D49CFA7B9F98 Q38533728-CACAC854-922E-40A8-813A-66AD98E7A5CE Q39091396-9194367F-4BD4-4F53-B366-D3DE695C8209 Q39138135-CA86C7F9-716E-4242-8594-2E3EA7FC76C0

P2860

Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.

http://www.wikidata.org/entity/Q52908090

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Lower motor neuron loss in mul ...... autoimmune encephalomyelitis.

@en

Lower motor neuron loss in mul ...... autoimmune encephalomyelitis.

@nl

type

label

Lower motor neuron loss in mul ...... autoimmune encephalomyelitis.

@en

Lower motor neuron loss in mul ...... autoimmune encephalomyelitis.

@nl

prefLabel

Lower motor neuron loss in mul ...... autoimmune encephalomyelitis.

@en

Lower motor neuron loss in mul ...... autoimmune encephalomyelitis.

@nl

P1433

Q52908090-BAE25CEF-0A54-4E37-B705-09283F1E7DCF

P1476

Q52908090-B7DC56D1-9978-4CA0-A993-6C174DF3A542

P2093

Q52908090-0A30C25E-EAFF-4B57-B221-EB75236CDC3E

Q52908090-2AF2B7F7-C9F7-408F-8A4B-0CF6B6C42AB4

Q52908090-2C61B53F-7E9D-4878-B32E-52E8C41DFAC0

Q52908090-5DDFBE39-07DF-49C0-AC56-A87B4BA835B0

Q52908090-5F9AAE72-B35C-44A9-872F-2A7599AA4402

Q52908090-6F5F5FB6-4C0A-498C-8E0F-1F9D2D3E61F6

Q52908090-7D974819-4E7F-43E2-8B63-40663BC969BF

Q52908090-A8E0B5BD-2A62-4862-8E9C-76888ED6BF80

Q52908090-C601CA97-95ED-4E7E-A6EF-20FD9EEE96EB

Q52908090-F4C9D352-CE26-459A-AB75-C9210A5C88B8

P2860

Q52908090-541270E4-0D85-454C-AB24-24423564B8EC

Q52908090-D3E36AE7-5395-42E7-B19A-026FF228DBA4

P304

Q52908090-4711BAE5-D46B-4661-BA26-2B2651BCDD48

P31

Q52908090-3462184C-3ED2-4360-BFC7-944F1C691459

P356

Q52908090-43AD1E83-5E01-41FB-A259-CFD74323B312

P433

Q52908090-BAF162D9-32F3-4079-B8DB-0AF247FF752D

P478

Q52908090-71C7ADD5-C2C6-4429-B040-47AF11554E39

P50

Q52908090-50C76045-FC65-4C2F-A12C-CEDDFCBC733A

Q52908090-BC077713-4E53-496C-852E-9B982EAFFE16

Q52908090-C085F94B-B481-4C29-BC34-BE24EAF3696A

Q52908090-D033E5A5-DEE0-4B8E-A376-B6720F9AAC0B

P577

Q52908090-59EE0D3D-7895-474A-BEC6-B0BA2A1F0340

P698

Q52908090-76A964D7-452B-42E1-BAB3-20CDD41CE9F5

P921

Q52908090-A09050EB-2329-4929-AC82-690FCCEBAE3C

Q52908090-E0CD04DB-A72B-4A2B-BEE9-27CC36FD1146

P356

P1433

Annals of Neurology

P1476

Lower motor neuron loss in mul ...... autoimmune encephalomyelitis.

@en

P2093

B Suman Bharathi

http://www.w3.org/2001/XMLSchema#string

Cedric S Raine

http://www.w3.org/2001/XMLSchema#string

Christoph Schmitz

http://www.w3.org/2001/XMLSchema#string

Jan Dörr

http://www.w3.org/2001/XMLSchema#string

Kathrin Müller-Wielsch

http://www.w3.org/2001/XMLSchema#string

Michael Tsokos

http://www.w3.org/2001/XMLSchema#string

Orhan Aktas

http://www.w3.org/2001/XMLSchema#string

Robert Glumm

http://www.w3.org/2001/XMLSchema#string

Robert Nitsch

http://www.w3.org/2001/XMLSchema#string

Susanne Dörr

http://www.w3.org/2001/XMLSchema#string

P2860

Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis.

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.

P304

310-322

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.21719

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Friedemann Paul

Harry W M Steinbusch

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19798635

http://www.w3.org/2001/XMLSchema#string

P921

experimental autoimmune encephalomyelitis

multiple sclerosis